Provides a framework for clinicians to identify patients susceptible to malignant hyperthermia based on genotypic and phenotypic findings.
Offers clinicians a framework to identify potential MH susceptibility; leaves open prospective validation of genotypic-phenotypic links.
This review identifies disease states associated with malignant hyperthermia susceptibility based on genotypic and phenotypic findings, and a framework is established for clinicians to identify a potentially malignant hyperthermia–susceptible patient.
No takes yet. Share an insight, caveat, or question.
Litman et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: